BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34769327)

  • 1. New Insights into the Role of PD-1 and Its Ligands in Allergic Disease.
    Galván Morales MA; Montero-Vargas JM; Vizuet-de-Rueda JC; Teran LM
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
    Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
    [No Abstract]   [Full Text] [Related]  

  • 3. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.
    Saha A; Aoyama K; Taylor PA; Koehn BH; Veenstra RG; Panoskaltsis-Mortari A; Munn DH; Murphy WJ; Azuma M; Yagita H; Fife BT; Sayegh MH; Najafian N; Socie G; Ahmed R; Freeman GJ; Sharpe AH; Blazar BR
    Blood; 2013 Oct; 122(17):3062-73. PubMed ID: 24030385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PI3Kδ Differentially Regulates Poly I:C- and Human Metapneumovirus-Induced PD-L1 and PD-L2 Expression in Human Bronchial Epithelial Cells.
    Ogawa T; Kan-O K; Shiota A; Fujita A; Ishii Y; Fukuyama S; Matsumoto K
    Front Immunol; 2021; 12():767666. PubMed ID: 34899719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2.
    Zak KM; Grudnik P; Magiera K; Dömling A; Dubin G; Holak TA
    Structure; 2017 Aug; 25(8):1163-1174. PubMed ID: 28768162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
    Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
    J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
    Karunarathne DS; Horne-Debets JM; Huang JX; Faleiro R; Leow CY; Amante F; Watkins TS; Miles JJ; Dwyer PJ; Stacey KJ; Yarski M; Poh CM; Lee JS; Cooper MA; Rénia L; Richard D; McCarthy JS; Sharpe AH; Wykes MN
    Immunity; 2016 Aug; 45(2):333-45. PubMed ID: 27533014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance.
    Veluswamy P; Wacker M; Scherner M; Wippermann J
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and interactions of the human programmed cell death 1 receptor.
    Cheng X; Veverka V; Radhakrishnan A; Waters LC; Muskett FW; Morgan SH; Huo J; Yu C; Evans EJ; Leslie AJ; Griffiths M; Stubberfield C; Griffin R; Henry AJ; Jansson A; Ladbury JE; Ikemizu S; Carr MD; Davis SJ
    J Biol Chem; 2013 Apr; 288(17):11771-85. PubMed ID: 23417675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative influence of programmed death-1-ligands on the survival of esophageal cancer patients treated with chemotherapy.
    Tanaka K; Miyata H; Sugimura K; Kanemura T; Hamada-Uematsu M; Mizote Y; Yamasaki M; Wada H; Nakajima K; Takiguchi S; Mori M; Doki Y; Tahara H
    Cancer Sci; 2016 Jun; 107(6):726-33. PubMed ID: 27015293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance.
    Schönrich G; Raftery MJ
    Front Cell Infect Microbiol; 2019; 9():207. PubMed ID: 31263684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PD-L1 and PD-L2 in allergic diseases and asthma.
    Singh AK; Stock P; Akbari O
    Allergy; 2011 Feb; 66(2):155-62. PubMed ID: 20722638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Mass Spectrometry Analysis of PD-L1 Protein Expression,
    Morales-Betanzos CA; Lee H; Gonzalez Ericsson PI; Balko JM; Johnson DB; Zimmerman LJ; Liebler DC
    Mol Cell Proteomics; 2017 Oct; 16(10):1705-1717. PubMed ID: 28546465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice.
    Li S; Tajiri K; Murakoshi N; Xu D; Yonebayashi S; Okabe Y; Yuan Z; Feng D; Inoue K; Aonuma K; Shimoda Y; Song Z; Mori H; Huang H; Aonuma K; Ieda M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection.
    Zhang E; Zhang X; Liu J; Wang B; Tian Y; Kosinska AD; Ma Z; Xu Y; Dittmer U; Roggendorf M; Yang D; Lu M
    PLoS One; 2011; 6(10):e26196. PubMed ID: 22022563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 signaling pathway in sepsis: Does it have a future?
    Chen R; Zhou L
    Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer.
    van Dam LS; de Zwart VM; Meyer-Wentrup FA
    Pediatr Blood Cancer; 2015 Feb; 62(2):190-197. PubMed ID: 25327979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
    Tanaka R; Ichimura Y; Kubota N; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Mizuno S; Takahashi S; Fujimoto M; Okiyama N
    J Invest Dermatol; 2022 Jan; 142(1):145-154.e8. PubMed ID: 34310947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease.
    Zhang X; Lu H; Peng L; Zhou J; Wang M; Li J; Liu Z; Zhang W; Zhao Y; Zeng X; Lu L
    Rheumatology (Oxford); 2022 Feb; 61(2):815-825. PubMed ID: 33930105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.